Product Name:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS:1273567-44-4
Molecular Formula:C11H19NO5
Purity:95%
Catalog Number:CM284795
Molecular Weight:245.28

Packing Unit Available Stock Price($) Quantity
CM284795-1g in stock ƏƏř

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1273567-44-4
Molecular Formula:C11H19NO5
Melting Point:-
Smiles Code:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
Density:
Catalog Number:CM284795
Molecular Weight:245.28
Boiling Point:384.0±42.0°C at 760 mmHg
MDL No:MFCD19442252
Storage:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products